Gilead To Present Late-Breaking Data Highlighting Antiviral Portfolio, Innovative Research Pipeline And HIV Leadership At IDWeek 2024
Gilead To Present Late-Breaking Data Highlighting Antiviral Portfolio, Innovative Research Pipeline And HIV Leadership At IDWeek 2024
Gilead Sciences, Inc. (NASDAQ:GILD) today announced the upcoming presentation of new findings from its antiviral research and development programs at IDWeek 2024, taking place from October 16-19. The data from 31 presentations across HIV treatment and prevention, COVID-19 and viral hepatitis include one late breaker abstract and six oral presentations, reflecting Gilead's commitment to helping address the evolving needs of a diverse range of people and communities affected by some of the world's most challenging viruses.– Latest Outcomes From HIV Prevention and Treatment Clinical Research, Including Data From Pivotal Phase 3 PURPOSE 1 & 2 Trials –
– 通過關鍵第3期PURPOSE 1和2試驗的HIV預防和治療臨床研究的最新結果 –
– Real World Evidence in COVID-19 Reinforce Veklury (remdesivir) as the Antiviral Standard of Care for the Treatment of People Hospitalized for COVID-19 –
– COVID-19現實世界證據強化Veklury（瑞德西韋）作爲治療因COVID-19住院患者的抗病毒標準關照 –
– Investigational Obeldesivir Safety and Tolerability Data From BIRCH and OAKTREE Trials Support Continued Evaluation as a Potential Treatment Option for RSV –
– 來自BIRCH和OAKTREE試驗的Obeldesivir研究數據支持繼續評估其作爲RSV的潛在治療選擇的安全性和耐受性 –
Gilead Sciences, Inc. (NASDAQ:GILD) today announced the upcoming presentation of new findings from its antiviral research and development programs at IDWeek 2024, taking place from October 16-19. The data from 31 presentations across HIV treatment and prevention, COVID-19 and viral hepatitis include one late breaker abstract and six oral presentations, reflecting Gilead's commitment to helping address the evolving needs of a diverse range of people and communities affected by some of the world's most challenging viruses.
吉利德科學公司（納斯達克：GILD）今天宣佈將在2024年IDWeek上展示其抗病毒研究和開發計劃的新發現，會議將於10月16日至19日舉行。31個關於HIV治療和預防、COVID-19和病毒性肝炎的演示包括一篇晚到摘要和六篇口頭演講，反映了吉利德致力於幫助解決受到世界上一些最具挑戰性病毒影響的不同人群和社區不斷變化的需求。
